Gilead Shares Are Trading Lower After the Company's Phase 3 TROPiCS-04 Study Missed Its Primary Endpoint of Overall Survival.
Gilead Shares Are Trading Lower After the Company's Phase 3 TROPiCS-04 Study Missed Its Primary Endpoint of Overall Survival.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.